News
CPhI South East Asia rescheduled for 2021
CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community more time to recover and to mitigate any global disruptions caused by COVID-19.
“The decision to reschedule...
News
Russia announces world’s first Covid-19 vaccine, Putin’s daughter gets vaccinated
Amid the race to develop a Covid-19 vaccine, Russian President Vladimir Putin launched a coronavirus vaccine, touted as the world's first such vaccine, too. The registration of the vaccine lays ground for mass inoculation even as the final stages...
News
Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020
Clinerion announced that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition 2020, a peer reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma, produced by Questex.
The competition highlights...
Clinical Trials
Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite
Phesi, a data-driven provider of clinical development analytics products and solutions, announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and management. The new...
News
Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service
Okapi Pharmacy, a wholly-owned subsidiary of Toppan Printing, a global leader in communication, security, packaging, décor materials, and electronics solutions, has announced the launch of Todokusuri EXPRESS, a service for delivering prescription medicines to patients through Todokusuri Yakkyoku, a...
News
YoSync Collaborates with IIIT Bangalore to Launch India’s First-Ever COVID-19 Blockchain Platform, BelYo
YoSync, a startup incubated at IIITB-IMACX Studios, signed a research collaboration in agreement with IIIT Bangalore, to partner with BelfricsBT, a Malaysian based blockchain startup. The partnership is aimed at jointly developing a blockchain platform for COVID-19. The project...
News
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID 19 vaccine with and without Matrix M™ adjuvant in healthy adults...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read